Healthcare · Pharmaceutical spending per capita

Pharmaceutical spending per capita in USA in 2026

In the United States, per capita spending on pharmaceuticals reaches 1.4 K $ — the highest figure among 197 countries. This record level stems from the unique structure of the American pharma market: the world's largest drug companies are based here, and prescription prices are significantly higher than in other developed nations. U.S. patients spend more on medicines than anyone else on the planet, driven by the high cost of innovative therapies and the specifics of the health insurance system. In 2026, the market continued to grow, fueled by an aging population and the launch of new expensive drugs.

Data for 2026 · unit: $
Position

USA world ranking

#2 / 197

Country position on the scale from last to first place for this indicator.

US
#2
#197#1
Trend

Change over time

Change in indicator over the available period.

300
1990
600
2000
1 K
2010
1.3 K
2020
1.4 K
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical spending per capita in USA — how much?
Based on 2026 data — 1.4 K $. This is rank #2 out of 197 countries.
What is USA's rank by Pharmaceutical spending per capita?
USA ranks #2 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in USA?
Over the available period the indicator changed from 300 to 1.4 K $.